LATEST ARTICLES

MOST POPULAR

Australia’s Emyria Readies For CBD Trial

Another Australian company eyeing the country's low-dose, prescription-free cannabidiol market is clinical-stage biotech company Emyria Limited (ASX: EMD).Last year we reported Australia’s Cann Group...

Georgia’s Hemp-Derived Cannabinoid Crackdown Nears

A bill tightening up the availability and nature of hemp derived cannabinoid products in Georgia has made its way to Governor Brian Kemp's desk...

Louisiana Industrial Hemp Program Progress

The Louisiana Department of Agriculture and Forestry (LDAF) announced late last week it has submitted rules and regulations for the state's industrial hemp program...

NZ’s Medsafe Approves Low-Dose CBD Without A Prescription

Certain forms of cannabidiol (CBD) medicines can now be legally purchased without a prescription in New Zealand. But as is the case across the...